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Abstract
The objective of this study was to evaluate effects of a combined use of extracts of medicinal herbs Taraxaumi
mongolicum, Viola yedoensis Makino, Rhizoma coptidis, and Radix isatidis (MYCI) on porcine epidemic diarrhea (PED).
Twenty-two 3-day-old piglets received an oral challenge with 3 × 103.5 TCID50 of the virulent PED virus (PEDV) in
PBS or PBS only and daily oral administration of 60 mg of the MYCI mixture suspended in milk replacer or the
vehicle for 7 days in a 2 × 2 factorial arrangement of treatments. Average daily gain (ADG) increased (p < 0.05) in
response to the MYCI treatment in the PEDV-challenged piglets (−18 vs. 7 g for the vehicle- vs. MYCI-administered
group), but not in unchallenged animals (27 vs. 28 g). Diarrhea score and fecal PEDV shedding, however, were not
influenced by the MYCI treatment. The PEDV challenge caused severe intestinal villus atrophy and crypt hyperplasia,
both of which were alleviated by administration of the MYCI mixture as indicated by an increase in the villus height
and a decrease in the crypt depth due to the treatment. Overall, medicinal herb extracts used in this study
ameliorated impaired growth performance and intestinal lesion of newborn piglets challenged with the virulent
PEDV. Therefore, our results suggest that the MYCI mixture could be used as a prophylactic or therapeutic agent
against PED.
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Background
The porcine epidemic diarrhea virus (PEDV) or genus
Alphacoronavirus causes an acute or sub-acute gastro-
intestinal disorder in pigs of all ages resulting in serious
economic losses across Europe and Asia [1–3]. Primary
clinical symptoms of the PEDV infection include acute
diarrhea, vomiting, weight loss, and dehydration [4, 5].
Moreover, an increased mortality as well as higher mor-
bidity in suckling piglets vs. older ones has also been
reported as to the damage of PEDV infection [6]. Many
attempts have been made to find effective prophylactic or
therapeutic agents against PEDV infection, but no satisfac-
tory agent has been reported to date [7, 8].
Medicinal herbs have been used as antimicrobial agents
for many years in Asian countries [9–12]. For example,
extracts of Houttuynia cordata are known to be effective
against herpes simplex virus type 1 (HSV-1), influenza
virus, human immunodeficiency virus type 1 (HIV-1) [13],
and coronavirus [14]. Moreover, Taraxacum mongolicum,
Viola yedoensis Makino, Rhizoma coptidis, and Radix
isatidis, which have been selected for the present study,
are also known to have antimicrobial and antiviral proper-
ties [15]. Taraxacum mongolicum has anti-inflammatory,
anti-carcinogenic, anti-allergic and anti-viral properties
[16–18] whereas extracts of Viola yedoensis Makino have
antiviral and antibacterial activities against HSV-1 and
Bacillus subtilis [19, 20]. Rhizoma coptidis, which contains
berberine as one of its active components, has a potent
antiviral activity against herpes virus as well as an
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antibacterial activity [21, 22]. Radix isatidis, roots and
leaves of which have been used in traditional Eastern medi-
cine for centuries to treat upper respiratory infections and
encephalitis, has been reported to have anti-inflammatory
[23] and antiviral effects against hepatitis, severe acute
respiratory syndrome (SARS), influenza, and epidemic en-
cephalitis [24] as well as a stimulatory action on macro-
phage phagocytosis [25].
Taraxacum mongolicum, Radix isatidis, Viola yedoensis
Makino, Rhizoma coptidis, and Radix isatidis are poten-
tially useful medicinal herbs for PED as could be extrapo-
lated from their antimicrobial activities described above.
To our knowledge, however, such a possibility has not
been examined to date. The present study was therefore
conducted to investigate the effects of a combined mixture
of extracts of the four herbs (MYCI) on growth perform-
ance, diarrhea, and intestinal morphology in newborn
piglets challenged with PEDV.
Methods
Animals and treatments
The experimental protocol regarding animal management
and care was approved by the Animal Care and Use
Committee of Kangwon National University. The MYCI
reagent used in the present study was prepared by mixing
powdered extracts of Taraxaci mongolia, Viola yedoensis
Makino, Rhizoma coptidis and Radix isatidis (Mayway
Co., USA) at a ratio of 1:1:1:2. Twenty-two 3-day-old
cross-bred [(Landrace × Yorkshire) × Duroc] suckling pig-
lets were obtained from a commercial farm that had not
implemented PEDV vaccination. The piglets were housed
individually and randomly assigned to one of four experi-
mental groups in a 2 × 2 factorial arrangement of
treatments with respect to a PEDV challenge and adminis-
tration of the MYCI mixture. The animals received an oral
administration of 3 × 103.5 TCID50 of PEDV in 3 mL of
phosphate-buffered saline (PBS) or PBS only following 12-
h fasting and daily administration of 60 mg of the MYCI
mixture suspended in 1 mL of milk replacer (CJ Feed,
Inc., Seoul) or the vehicle for 7 days. Calculated chemical
composition of the milk replacer is presented in Table 1.
All animals had a free access to water and the milk replacer
throughout the experiment. Feces was obtained directly
from the rectum of each piglet at 12 and 24 h and daily
after d 1 post-challenge. Fecal consistency was scored
according to a 4-ladder scale as described previously [26]:
0, firm feces; 1, soft feces; 2, mild diarrhea; 3, severe diar-
rhea. All animals were killed by electric stunning upon
termination of the feeding trial, and the duodenum,
jejunum, and ileum were dissected also as described [26].
Detection of fecal shedding of PEDV
RNA contained in the feces was extracted using RNasy
Mini Kit® (QIAGN, Germany) after removal of contami-
nants by centrifugation for 10 min at 4000 × g. Presence of
PEDV in the sample was identified by the reverse
transcription-polymerase chain reaction (RT-PCR) target-
ing a coding region of the membrane protein of the PEDV
[14]. The base sequences of the forward and reverse
primers were 5’-GGGCGCCTGTATAGAGTTTA-3’ and
5’-AGACCACCAAGAATGTGTCC-3’, respectively. The
PCR conditions were initial denaturation at 95 °C for
2 min, 35 cycles of 95 °C for 20 s, 56 °C for 40 s, and 72 °
C for 1 min, and final extension at 72 °C for 3 min. A 412-
bp PCR product was identified by the agarose gel
electrophoresis.
Histopathological examination
The intestinal tissue was fixed in a 10 % neutral formalin
solution. The fixed tissue was embedded in paraffin, sec-
tioned to a 4-μm thickness, stained with hematoxylin and
eosin, and subjected to measurement of the villus height
(VH) and crypt depth (CD) under a microscopic field as
previously described [26].
Statistical analysis
Data were analyzed using the GLM procedure of SAS
(SAS Inst., USA) in all variables except for fecal PEDV
shedding. The statistical model included the PEDV chal-
lenge and administration of the MYCI mixture as main
effects as well as their interaction. In the frequency of
fecal PEDV shedding, which was analyzed using the chi-
squared test of SAS, effects of the PEDV challenge and




The initial and final weights of the newborn piglets did
not differ between the PEDV-challenged and unchallenged
piglets or between the MYCI mixture-administered piglets
and the vehicle (milk replacer)-administered (control)
ones (Table 2). However, average daily gain (ADG) during
the 7-d experimental period decreased (p < 0.01) due to
the challenge (27 vs. −6 g for the unchallenged vs. chal-
lenged group). The ADG increased (p < 0.05) in response
Table 1 Calculated chemical composition of the milk replacer
Item Value
Crude protein (%) 20.5
Crede fat (%) 15.0
Crude fiber (%) 3.0
Crude ash (%) 11.0
Calcium (%) 0.8
Phosphorous (%) 1.5
Vitamin A (U/kg) 40,000
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to administration of the MYCI mixture (17 g vs. 4 g for
the MYCI vs. control group). Moreover, ADG increased
due to administration of the MYCI mixture in the chal-
lenged piglets, but not in the unchallenged ones.
Diarrhea and detection of fecal shedding of PEDV
The piglets challenged with PEDV exhibited watery diar-
rhea beginning from d 2 post-challenge while unchal-
lenged piglets had normal firm feces throughout the
experiment (Figure 1). Administration of the MYCI
mixture had no effect on the fecal consistency score. The
presence of PED virus in the feces and in the small intes-
tines was examined by RT-PCR (Table 3 and Fig. 2). When
the virus was detected, it was present in both feces and
small intestine (Fig. 2). The PEDV was detected in feces
from d 1 through the end of the experiment only in the
challenged piglets (Table 3). Moreover, the effect of the
challenge on the frequency of the fecal PEDV shedding on
d 1 onwards was significant (p < 0.05) whereas the effect
of the MYCI administration was not significant at any
time point of the experiment.
Intestinal morphology
The PEDV-challenged piglets exhibited a severe atrophy
in the villus structure as well as hyperplasia with infiltra-
tion of inflammatory cells in the crypt in the duodenum,
jejunum, and ileum when their intestinal morphology
was compared with that of the unchallenged piglets
(Fig. 3). The villus atrophy and crypt hyperplasia due to
the PEDV infection were alleviated when the MYCI mix-
ture was administered to the challenged piglets.
The VH in the duodenum decreased due to the PEDV
challenge, but it increased in response to administration
of the MYCI mixture (Table 4). Duodenal CD, however,
was not influenced by the challenge or administration of
the MYCI mixture. The VH:CD ratio in the duodenum
was greater in the MYCI mixture-administered group vs.
the control only in the animals challenged with PEDV.
In the Jejunum, VH, which did not change due to the
challenge, increased in response to administration of the
MYCI mixture. The CD in the jejunum increased due to
the challenge. Moreover, CD in this region decreased in
response to administration of the MYCI mixture, which
was apparent only in the PEDV-challenged animals. The
VH in the ileum also increased due to administration of
the MYCI mixture, which was apparent only in the
PEDV-challenged animals. The CD in the ileum de-
creased due to the PEDV challenge as well as adminis-
tration of the MYCI mixture.
Discussion
While only sporadic PED outbreaks were reported in
Europe during the past few decades, PEDV infection has
caused enormous economic losses in the pig industry in
Asian countries including China, South Korea and
Vietnam during the same period. Furthermore, swine
farmers in North America have also been experiencing
devastating economic losses resulting from prevalence of
PED since its outbreak in April of 2013 in the USA [27].
Because the efficacy of PEDV vaccines is not good enough
Table 2 Effects of oral administration of the MYCI mixture on growth performance of newborn piglets after an oral administration
of PEDVa)
Not challenged Challenged (Chal) P-value
CONb) (n = 5) MYCI (n = 5) SEM CON (n = 6) MYCI (n = 6) SEM Chal MYCI C × M
Initial wt, kg 2.61 2.69 0.251 2.55 2.60 0.229 0.758 0.801 0.946
Final wt, kg 2.80 2.89 0.258 2.43 2.65 0.235 0.232 0.545 0.797
ADGb), g 27 28 5.1 −18 7 4.7 <0.001 0.016 0.029
aNewborn piglets received an oral challenge with 3 × 103.5 TCID50 of PEDV in PBS or PBS only and daily administration 60 mg of the MYCI mixture suspended in
milk replacer or the vehicle for 7 days
bCON, control; ADG, average daily gain
Fig. 1 Effects of the oral PEDV challenge and administration of
the MYCI mixture on fecal consistency score of newborn piglets.
Newborn piglets received a challenge with 3 × 103.5TCID50 of PEDV
in PBS or PBS only and daily administration of 60 mg of the MYCI
mixture suspended in milk replacer or the vehicle. Rectal feces was
scored according to a 4-ladder scale: 0, firm feces; 1, soft feces; 2,
mild diarrhea; 3, severe diarrhea. The effect of the PEDV challenge
was significant (p < 0.05)
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to prevent PEDV infection, it has been a research focus to
search for safe, inexpensive and effective measures to pre-
vent or treat PED. Accordingly, a variety of studies includ-
ing the present one have been conducted in Europe, Asia,
and America to find antiviral agents in medicinal herbs as
a means of alternative medicine [6, 28].
Diarrhea and vomiting are the main clinical signs of
PEDV infection resulting in suboptimal growth perform-
ance in suckling piglets [29]. The decreased ADG as well
as diarrhea of the newborn piglets following the PEDV
challenge in the present study was thus consistent with
the known clinical signs of the virus infection [29, 30].
More importantly, administration of the MYCI mixture
alleviated the growth check of the piglets due to the
PEDV infection.
The PEDV infection causes gross and microscopic le-
sions such as severe atrophic enteritis with villous fusion
similar to those found in the infection of the transmis-
sible gastroenteritis virus [29, 31]. The atrophied villus
structure as well as crypt hyperplasia indicated by the
decreased VH and increased CD observed in the PEDV-
challenged piglets was therefore consistent with the
known histopathological signs of the PEDV infection.
Furthermore, the increase in VH in the duodenum, je-
junum, and ileum as well as the decrease in CD in the
jejunum and ileum in response to administration of the
MYCI mixture indicates that the MYCI recipe has a
beneficial effect on the integrity of the intestinal mucosal
structure of the piglets infected with PEDV.
The ultimate goal of PEDV vaccination is to prevent
PEDV infection. However, currently available PEDV vac-
cines are not effective enough to prevent PED, although
some of the vaccines are effective for alleviating fecal
virus shedding and the severity of the clinical signs of
PED [6]. In this regard, administration of the MYCI
mixture was not effective for reducing the frequency of
fecal PEDV shedding in the challenged piglets with all its
positive effects on the integrity of the intestinal mucosal
structure. Nevertheless, it is thought to be worth trying
to examine if a combined use of a PEDV vaccine and the
MYCI mixture has any synergistic prophylactic or thera-
peutic effect in PED.
A number of phytochemicals contained in medicinal
plants, which include limonoids, alkaloids, lignana, orga-
nosulfur, furyl, thiophenes, polylines, terpenoids, flavo-
noids, polyphenolics, sulphides, saponins, coumarins,
and chlorophyllins, are known to exhibit the antiviral
effects by blocking viral entry or RNA/DNA replication
or by virtue of their anti-oxidant activity [32]. Likewise,
active antiviral phytochemicals, i.e. 11β,13-dihydrotaraxi-
nic acid, 6,7-dimethoxycoumarin, berberine, and indiru-
bin, have been identified in Taraxaumi mongolicum [33],
6,7- Viola yedoensis Makino [34], Rhizoma coptidis [21],
Table 3 Effects of oral administration of the MYCI mixture on fecal PEDV shedding of newborn piglets after an oral administration
of the virusa)
Time Not challenged Challenged (Chal) p-value
Control (n = 5) MYCI (n = 5) Control (n = 6) MYCI (n = 6) Chal MYCI
0 h 0/5 0/5 0/6 0/6 N/Ab N/A
12 h 0/5 0/5 0/6 0/6 N/A N/A
1 d 0/5 0/5 2/6 2/6 0.044 1.000
2 d 0/5 0/5 6/6 6/6 <0.001 1.000
3d 0/5 0/5 6/6 5/6 <0.001 0.670
4 d 0/5 0/5 4/6 2/6 0.009 0.338
5 d 0/5 0/5 4/6 3/6 0.003 0.647
6 d 0/5 0/5 3/5c 3/6 0.006 0.890
7 d 0/5 0/5 2/5 2/6 0.034 0.916
Total 0/45 0/45 27/52 23/54 <0.001 0.460
aNewborn piglets received an oral challenge with 3 × 103.5 TCID50 of PEDV in PBS or PBS only and daily administration 60 mg of the MYCI mixture suspended
in milk replacer or the vehicle for 7 days. Presence of the PEDV in feces was determined by reverse transcription-polymerase chain reaction. Data represent the
number of PEDV-positive animals per total animals
bN/A, Not applicable
cOne animal died
Fig. 2 PED virus detection in the small intestine and fecal samples
using RT-PCR assay. Lane M; 100 bp DNA ladder. Lanes 1 and 6; a
412-bp PCR product (membrane protein of the PED virus; a positive
control). Lanes 2 and 7; negative controls. Lanes 3–5; small intestine
samples of the PED virus challenged piglets on d 7. Lanes 8–10; fecal
samples of the PED virus challenged piglets on d 7
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Fig. 3 Effects of the oral PEDV challenge and administration of the MYCI mixture on intestinal morphology of newborn piglets (100× magnification).
Newborn piglets received a challenge with 3 × 103.5TCID50 of PEDV in PBS or PBS only and daily administration of 60 mg of the MYCI
mixture suspended in milk replacer or the vehicle for 7 days. Note the atrophied and fused villi as well as crypt hyperplasia in the
challenged/control group and the alleviation of the atrophy and fusion of the villi and the crypt hyperplasia in the challenged/MYCI
group compared with the morphology in the former. Only representative results are shown in this figure
Table 4 Effects of oral administration of the MYCI mixture on intestinal mucosal morphology of newborn piglets after an oral
administration of PEDVa)
Not challenged Challenged (Chal) P-value
CONb) (n = 5) MYCI (n = 5) SEM CON (n = 6) MYCI (n = 6) SEM Chal MYCI C × M
Duodenum
VHb), μm 443 482 38.3 409 471 31.7 0.050 <0.001 0.023
CDb), μm 171 171 10.7 183 173 16.1 0.183 0.255 0.533
VH:CD 2.65 2.72 0.163 2.31 2.74 0.149 0.590 0.392 0.002
Jejunum
VH, μm 144 151 11.7 129 154 13.3 0.156 0.002 0.030
CD, μm 157 137 13.0 170 138 9.5 0.040 <0.001 0.001
VH:CD 0.98 1.18 0.166 0.89 1.23 0.155 0.946 0.377 0.013
Ilium
VH, μm 166 182 13.3 161 184 10.1 0.648 <0.001 0.015
CD, μm 165 166 15.9 160 142 11.0 0.001 0.027 0.048
VH:CD 1.12 1.16 0.156 1.01 1.32 0.170 0.933 0.547 0.058
aNewborn piglets received an oral challenge with 3 × 103.5 TCID50 of PEDV in PBS or PBS only and daily administration 60 mg of the MYCI mixture suspended in
milk replacer or the vehicle for 7 days
bCON, control; VH, villus height; CD, crypt depth
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and Radix isatidis [35], respectively, extracts of which
were used in the present study. It also seems possible
that there exist more active phytochemicals other than
those described above in those herb extracts used in the
present study, because the list of active components
contained in medicinal herb extracts is rapidly expand-
ing [36]. Overall, the present results suggest that admin-
istration of the MYCI mixture is a promising recipe
which could be used as a prophylactic or therapeutic
measure for PED.
Conclusions
We evaluated effects of a combined use of extracts of
medicinal herbs Taraxaumi mongolicum, Viola yedoensis
Makino, Rhizoma coptidis, and Radix isatidis (MYCI) on
PED. In summary, medicinal herb extracts used in this
study ameliorated impaired growth performance and
intestinal lesion of newborn piglets challenged with the
virulent PEDV. Therefore, our results suggest that the
MYCI mixture could be used as a prophylactic or thera-
peutic agent in PED.
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